Tsunoda T - Search Results

1

Clonal and functional analysis for the augmentation of tumour-infiltrating lymphocytes by interleukin 4.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Noguchi K, Hotta T, Mizobata S, Arii K. Tsunoda T, et al. Br J Cancer. 1996 Oct;74(7):1085-9. doi: 10.1038/bjc.1996.494. Br J Cancer. 1996. PMID: 8855979 Free PMC article.

2

Enhancement of tumor cell susceptibility to tumor-infiltrating lymphocytes by cisplatin.

Noguchi K, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tani M, Tamai M, Hotta T, Mizobata S, Arii K. Noguchi K, et al. Among authors: tsunoda t. J Cancer Res Clin Oncol. 1997;123(6):345-51. doi: 10.1007/BF01438311. J Cancer Res Clin Oncol. 1997. PMID: 9222301

3

Antitumor effects of interleukin-2 gene-modified fibroblasts in an orthotopic colon cancer model.

Terasawa H, Tanimura H, Nakamori M, Tsunoda T, Iwahashi M, Tani M, Yamaue H. Terasawa H, et al. Among authors: tsunoda t. Jpn J Cancer Res. 1999 Sep;90(9):1000-6. doi: 10.1111/j.1349-7006.1999.tb00848.x. Jpn J Cancer Res. 1999. PMID: 10551331 Free PMC article.

4

Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas.

Tanaka H, Tsunoda T, Nukaya I, Sette A, Matsuda K, Umano Y, Yamaue H, Takesako K, Tanimura H. Tanaka H, et al. Among authors: tsunoda t. Br J Cancer. 2001 Jan 5;84(1):94-9. doi: 10.1054/bjoc.2000.1547. Br J Cancer. 2001. PMID: 11139320 Free PMC article.

5

Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.

Umano Y, Tsunoda T, Tanaka H, Matsuda K, Yamaue H, Tanimura H. Umano Y, et al. Among authors: tsunoda t. Br J Cancer. 2001 Apr 20;84(8):1052-7. doi: 10.1054/bjoc.2000.1715. Br J Cancer. 2001. PMID: 11308253 Free PMC article.

6

Specific T-cell immunity against Ki-ras peptides in patients with pancreatic and colorectal cancers.

Shono Y, Tanimura H, Iwahashi M, Tsunoda T, Tani M, Tanaka H, Matsuda K, Yamaue H. Shono Y, et al. Among authors: tsunoda t. Br J Cancer. 2003 Feb 24;88(4):530-6. doi: 10.1038/sj.bjc.6600697. Br J Cancer. 2003. PMID: 12592366 Free PMC article.

7

Cisplatin modulates tumor cell susceptibility to tumor-infiltrating lymphocytes in vivo.

Noguchi K, Tanimura H, Yamaue H, Iwahashi M, Tsunoda T, Tani M, Hotta T, Mizobata S, Arii K, Tamai M. Noguchi K, et al. Among authors: tsunoda t. Oncol Rep. 1997 Sep-Oct;4(5):927-30. doi: 10.3892/or.4.5.927. Oncol Rep. 1997. PMID: 21590168

8

In vitro augmentation of the cytotoxic activity of peripheral blood mononuclear cells and tumor-infiltrating lymphocytes by famotidine in cancer patients.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Arii K, Noguchi K. Tsunoda T, et al. Int J Immunopharmacol. 1992 Jan;14(1):75-81. doi: 10.1016/0192-0561(92)90107-v. Int J Immunopharmacol. 1992. PMID: 1582736

9

Functional and phenotypic analyses of interleukin 2-activated tumor-infiltrating lymphocytes.

Yamaue H, Tanimura H, Tsunoda T, Iwahashi M, Tani M, Tamai M, Inoue M. Yamaue H, et al. Among authors: tsunoda t. Biotherapy. 1990;2(3):247-59. doi: 10.1007/BF02173526. Biotherapy. 1990. PMID: 1698423

10

Augmentation of cytotoxic activity by combination with interleukin 2 and interferon gamma.

Tsunoda T, Tanimura H, Yamaue H, Iwahashi M, Tani M, Tamai M, Noguchi K, Arii K, Hotta T. Tsunoda T, et al. Nihon Geka Hokan. 1991 Nov 1;60(6):396-405. Nihon Geka Hokan. 1991. PMID: 1820012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,191 results

Search Page

Filters